This announcement is a separate document:
中源协和细胞基因工程股份有限公司2023年第三季度报告
Zhongyuan Xiehe Cell Genetic Engineering Co., Ltd. 2023 Third Quarter Report
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Latest
05:31
The Prime Ministers of Italy and Lebanon held a meeting to discuss the situation in Syria.
05:29
The acting president of South Korea emphasized the importance of national governance stability.
05:27
The scale of Increase Stake & Buy Back in the A-share market has reached a new high in 10 years, with the total amount of Increase Stake & Buy Back by listed companies exceeding 240 billion yuan this year.
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.